Loading insider details...
Beta
Latest Form 4 (Sep 17, 2026): Grant/Award of 1,187 KRYS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | Krystal Biotech, Inc. (KRYS) | Grant/Award | 1,187 | n/a |
| Mar 3, 2026 | Krystal Biotech, Inc. (KRYS) | Sale | 9,430 | $2.60M |
| Feb 26, 2026 | Krystal Biotech, Inc. (KRYS) | Exercise/Conversion | 37,895 | $93.2K |
| Jun 30, 2025 | Krystal Biotech, Inc. (KRYS) | Grant/Award | 5,000 | n/a |
| Jul 1, 2024 | Krystal Biotech, Inc. (KRYS) | Grant/Award | 5,000 | n/a |
| Jul 3, 2023 | Krystal Biotech, Inc. (KRYS) | Grant/Award | 6,800 | n/a |
| Jun 9, 2023 | Krystal Biotech, Inc. (KRYS) | Sale | 4,604 | $589.1K |
| May 23, 2023 | Krystal Biotech, Inc. (KRYS) | Sale | 50,000 | $4.75M |
| May 11, 2023 | Krystal Biotech, Inc. (KRYS) | Sale | 17,100 | $1.55M |
| Apr 21, 2023 | Krystal Biotech, Inc. (KRYS) | Sale | 7,900 | $713.5K |